OTHR-10. Diverse survival outcomes of HER2+ Breast Cancer Brain Metastases (BrCBM) presenting with isolated brain relapse compared to those with concurrent extracranial disease

BACKGROUND: In patients with isolated HER2+ BrCBM and no extracranial disease (ECD), there are no consensus guidelines on optimal treatment approaches following CNS-directed therapy. Our goal was to determine the implications of ECD at time of first HER2+ BrCBM on intracranial progression-free survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Noteware, Laura, Ramirez, Luis, Alder, Laura, Dalal, Nicole, Herndon, James E, Floyd, Scott R, Van Swearingen, Amanda E D, Anders, Carey K, Sammons, Sarah L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351270/
http://dx.doi.org/10.1093/noajnl/vdab071.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351270/
http://dx.doi.org/10.1093/noajnl/vdab071.065

Ejemplares similares